Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Transfer Factor is a term for immune-modulating extracts, typically derived from cow colostrum or egg yolk, that are suggested to "transfer" antigen-specific cell-mediated immunity. The use of Transfer Factor for Epstein-Barr Virus (EBV) is primarily based on the rationale that it may enhance immune response against chronic viral infections. Some small clinical studies and case reports, mostly from the 1970s to early 2000s, have explored Transfer Factor for viral infections, including EBV-associated conditions such as chronic fatigue syndrome. These studies are generally limited by small sample sizes, lack of rigorous controls, and variable product composition.

A 2001 review in the journal Biotherapy summarized several small trials suggesting that Transfer Factor may be beneficial in chronic viral illnesses including EBV, but concluded that evidence is preliminary and further research is needed. There is a lack of large, well-controlled, modern clinical trials specifically evaluating Transfer Factor for EBV infection. As a result, while there is some scientific rationale and a small body of suggestive clinical evidence, the overall quality and strength of the evidence is low. The use of Transfer Factor for EBV is not widely endorsed in mainstream medicine, and most recommendations are found in alternative or integrative medicine circles.

In summary, there is limited scientific evidence suggesting potential benefit of Transfer Factor in supporting immune response to EBV, but robust, high-quality clinical data are lacking.

More about Transfer Factor
More about Epstein Barr Virus

Other ingredients used for Epstein Barr Virus

Other health conditions supported by Transfer Factor

Products containing Transfer Factor